Several studies in the past few years have also identified a role for TRPV2 in cardiac function, and have suggested that inhibition of TRPV2 activity may be a potential target for the treatment of cardiomyopathy and heart failure [30,31,32,33]. The gene discussed is TRPV2; the disease is cardiomyopathy.